Healthcare utilization and costs in patients with rheumatoid arthritis using biologics or tofacitinib: a nationwide, population-based study - Top-Institutions - MDSpire

Healthcare utilization and costs in patients with rheumatoid arthritis using biologics or tofacitinib: a nationwide, population-based study

  • By

  • Yen-Ju Chen

  • Wei-Li Ho

  • Hsian-Min Chen

  • Yi-Ming Chen

  • Hsin-Hua Chen

  • June 22, 2026

  • 0 min

Share

Top Institutions in Rheumatology

Brief introduction explaining scope and methodology.

  • #1

    Taiwan's National Health Insurance Research Database
    Taiwan's National Health Insurance Research Database

    Taipei, Taiwan

    Key Differentiators

    • Rheumatology

  • #2

    American College of Rheumatology
    American College of Rheumatology

    Atlanta, Georgia

    Key Differentiators

    • Rheumatology

  • #3

    Taiwan’s National Health Insurance Administration
    Taiwan’s National Health Insurance Administration

    Taipei, Taiwan

    Key Differentiators

    • Rheumatology

Original Source(s)

Healthcare utilization and costs in patients with rheumatoid arthritis using biologics or tofacitinib: a nationwide, population-based study

  • by Yen-Ju Chen, Wei-Li Ho, Hsian-Min Chen, Yi-Ming Chen, Hsin-Hua Chen

  • June 22, 2026

Related Content

Kinesio Taping Shows Limited, Uncertain Benefits

Researchers find effects vary by timing, comparator, and outcome across musculoskeletal disorders

Depressive symptoms and risk of incident activities of daily living disability among older adults with symptomatic arthritis

Mandatory Training Modules Deserve a Harder Look

A JAMA Viewpoint argues that 4 million physician-hours spent on compliance modules each year warrants institutional reassessment.